The role of ultrasound and Doppler analysis in the diagnosis of polycystic ovary syndrome

Ultrasound in Obstetrics and Gynecology

Volumn 22, Issue 3, 2003, Pages 225-232

  Battaglia, C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL FUNCTION; ADRENAL HYPERPLASIA; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; DISEASE COURSE; DOPPLER FLOWMETRY; EDITORIAL; ENZYME DEFICIENCY; HISTORY OF MEDICINE; HUMAN; HYPERANDROGENISM; HYPERINSULINISM; INSULIN RESISTANCE; LUTEINIZING HORMONE RELEASE; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ULTRASOUND;

BLOOD FLOW VELOCITY; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; OVARY; POLYCYSTIC OVARY SYNDROME; ULTRASONOGRAPHY, DOPPLER;

EID: 0042877273     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1002/uog.228     Document Type: Editorial

References (117)

1. Vallisneri A. Storia della generazione dell'uomo e dell'animale; 1721. Cited in Cooke ID, Lunenfeld B. Res Clin Forums 1989; 11: 109-113.
2. Vallisneri A. Storia della generazione dell'uomo e dell'animale; 1721. Cited in Cooke ID, Lunenfeld B. Res Clin Forums 1989; 11: 109-113.
3. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181-191.
4. Vara P, Niemineva K. Small cystic degeneration of ovaries as incidental finding in gynecological laparotomies. Acta Obstet Gynecol Scand 1951; 31: 94-99.
5. Sommers SC, Wadman PJ. Pathogenesis of polycystic ovaries. Am J Obstet Gynecol 1956; 29: 181-187.
6. Clayton RN, Ogden V, Hodgkinson J, Worswich L, Rodin DA, Dyer S, Meade TW. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf) 1992; 37: 127-134.
7. Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ 1986; 293: 335-359.
8. Hull MGR. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1987; 1: 235-245.
9. Polson DW, Wadsworth J, Adams J, Franks S. Polycystic ovaries: a common finding in normal women. Lancet 1988; 1: 870-872.
10. Yen SSC. Chronic anovulation caused by peripheral endocrine disorders. In Reproductive Endocrinology, Yen SSC, Jaffe RB, Barbieri RL (eds). WB Saunders: Philadelphia, PA, 1991; 593-625.
11. Axelrod LR, Goldzieher JW, Ross SD. Concurrent 3-beta-hydroxysteroid dehydrogenase deficiency in adrenal and sclerocystic ovary. Acta Endocrinol 1965; 48: 392-412.
12. Futterweit W, Krieger DT. Pituitary tumor associated with hyperprolactinemia and polycystic ovarian disease. Fertil Steril 1979; 31: 608-613.
13. Alger M, Vazquez-Matute L, Mason M, Canales E, Zarate A. Polycystic ovarian disease associated with hyperprolactinemia and defective metoclopramide response. Fertil Steril 1980; 34: 70-71.
14. Lisse K, Schurenkamper P, Friedrich W, Rutkowsky J. Diurnal change of serum androstenedione and testosterone and response to hCG and dexamethasone in women with polycystic ovaries, adrenal hyperandrogenism and unexplained hirsutism. Acta Endocrinol 1980; 93: 216-222.
15. Lobo RA, Goebelsmann U. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease. Am J Obstet Gynecol 1980; 138: 720-726.
16. Stevens VC, Goldzieher JV. Urinary excretion of gonadotropins in congenital hyperplasia. Pediatrics 1986; 41: 421-427.
17. Insler V, Shoham Z, Barash A, Koistinen R, Seppala M, Hen M, Lunenfeld B, Zadik Z. Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings. Hum Reprod 1993; 8: 379-384.
18. Insler V, Lunenfeld B. Pathophysiology of polycystic ovarian disease: new insights. Hum Reprod 1991; 6: 1025-1029.
19. Achard C, Thiers J. Le virilisme pilaire et son association a l'insuffisance glycolytique (diabetes des femme a barbe). Bull Acad Natl Med 1921; 86: 51-83.
20. Lobo RA, Carmina E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 2000; 132: 989-993.
21. Adashi E, Hsueh A, Yen SSC. Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 1981; 108: 1441-1449.
22. Dahlgren E, Janson PO. Polycystic ovary syndrome - long-term metabolic consequences. Int J Gynecol Obstet 1994; 44: 3-8.
23. Homburg R. Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod 1996; 11: 29-39.
24. Poretsky L, Piper B. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet Gynecol 1994; 84: 613-621.
25. Seino S, Seino M, Bell GI. Human insulin-receptor gene. Diabetes 1990; 39: 129-133.
26. Julier C, Weil D, Couillin P, Cote JC, Nguyen VC, Foubert C, Boue A, Thirion JP, Kaplan JC, Junien C. The beta chorionic gonadotropin-beta luteinizing gene cluster maps to human chromosome 19. Hum Genet 1984; 67: 174-177.
27. Battaglia C, Regnani G, Mancini F, Iughetti L, Bernasconi S, Volpe A, Flamigni C, Venturoli S. Isolated premature pubarche: ultrasonographic and color Doppler analysis - A longitudinal study. J Clin Endocrinol Metab 2002; 87: 3148-3154.
28. Battaglia C, Regnani G, Mancini F, Iughetti L, Flamigni C, Venturoli S. Polycystic ovaries in childhood: a common finding in daughters of PCOS patients. A pilot study. Hum Reprod 2002; 17: 771-776.
29. Hague WM, Adams J, Rodda C, Brook CGD, de Bruyn R, Grant DB, Jacobs HS. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol (Oxf) 1990; 33: 501-510.
30. Legro RS. The genetics of polycystic ovary syndrome. Am J Med 1995; 98: 9S-16S.
31. Govind A, Obharl MS, Clayton RN. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 1999; 84: 38-43.
32. Azziz R. The time has come to simplify the evaluation of the hirsute patient. Fertil Steril 2000; 74: 870-872.
33. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774-800.
34. Homburg R. What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome. Hum Reprod 2002; 17: 2495-2499.
35. Goldzieher JW, Axelrod LR. Clinical and biochemical features of polycystic ovarian disease. Fertil Steril 1963; 14: 631-653.
36. Kazer R, Kessel B, Yen S. Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1987; 65: 233-236.
37. Koskinen P, Penttila TA, Anttila L, Erkkola R, Irjala K. Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome. Fertil Steril 1996; 65: 517-522.
38. Eden JA. Which is the best way to detect the polycystic ovary? Aust N Z J Obstet Gynaecol 1988; 28: 221-224.
39. Saxton DW, Farquhar CM, Rae T, Beard RW, Anderson MC, Wadsworth J. Accuracy of ultrasound measurements of female pelvic organs. Br J Obstet Gynaecol 1990; 97: 695-699.
40. Cheung AP, Chang RJ. Polycystic ovary syndrome. Clin Obstet Gynecol 1990; 33: 655-667.
41. Kratochwil A, Urban GU, Friedrich F. Ultrasonic tomography of the ovaries. Ann Chir Gynaecol 1972; 61: 211-214.
42. van Santbrink EJP, Hop WC, Fauser BCJM. Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 1997; 67: 452-458.
43. Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, Morris DV, Price J, Jacobs HS. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 1985; ii: 1375-1378.
44. Battaglia C, Volpe A. Ultrasound and Doppler studies in polycystic ovarian syndrome. In Ultrasound and Infertility, Kupesic S, de Ziegler D (eds). Parthenon Publishing, London, 2000; 53-65.
45. Parisi L, Tramonti M, Derchi LE, Castiano S, Zurli A, Rocchi P. Polycystic ovarian disease: ultrasonic evaluation and correlations with clinical and hormonal data. J Clin Ultrasound 1984; 12: 21-26.
46. Yee B, Barnes RB, Vargyas JM, Marrs RP. Correlation of transabdominal and transvaginal ultrasound measurements of follicle size and number with laparoscopic findings for in vitro fertilization. Fertil Steril 1987; 47: 828-832.
47. Fauser BCJM. Classification of chronic hyperandrogenic anovulation. In Chronic Hyperandrogenic Anovulation, Coeling-Bennink HJT, Vemer HM, van Keep PA (eds). Parthenon: Carnforth, 1991; 11-15.
48. Hull MGR. Polycystic ovarian disease: clinical aspects and prevalence. Res Clin Forums 1989; 11: 21-34.
49. Timor-Tritsch IE, Bar-Yam Y, Elgali S, Rottem S. The technique of transvaginal sonography with the use of a 6.5 MHz probe. Am J Obstet Gynecol 1988; 158: 1019-1024.
50. Pache TD, Wladimiroff JW, Hop WCJ, Fauser BCJ. How to discriminate between normal and polycystic ovaries: transvaginal US study. Radiology 1992; 183: 421-423.
51. Goldstein SR. Incorporating endovaginal ultrasonography into the overall gynecologic examination. Am J Obstet Gynecol 1990; 162: 625-632.
52. Mendelson EB, Bohm-Velez M, Neiman HL, Russo J. Transvaginal sonography in gynecologic imaging. Sem Ultrasound CT MR 1988; 9: 102-121.
53. Feichtinger W, Kemeter P. Transvaginal sector scan sonography for needle guided transvaginal follicle aspiration and other applications in gynecologic routine and research. Fertil Steril 1986; 45: 722-725.
54. Battaglia C, Artini PG, D'Ambrogio G, Galli PA, Genazzani AR. Uterine and ovarian blood flow measurement. Does the full bladder modify the flow resistance? Acta Obstet Gynecol Scand 1994; 73: 716-718.
55. Takahashi K, Ozaki T, Okada M, Uchida A, Kitao M. Relationship between ultrasonography and histopathological changes in polycystic ovarian syndrome. Hum Reprod 1994; 9: 2255-2258.
56. Takahashi K, Eda Y, Okada S, Abu-Musa A, Yoshino K, Kitao M. Morphological assessment of polycystic ovary using transvaginal ultrasound. Hum Reprod 1993; 8: 844-849.
57. Battaglia C, Genazzani AD, Salvatori M, Giulini S, Artini PG, Genazzani AR, Volpe A. Doppler, ultrasonographic and endocrinological environment with regard to the number of small subcapsular follicles in polycystic ovary syndrome. Gynecol Endocrinol 1999; 13: 123-129.
58. Yeh HC, Futterweit W, Thornton JC. Polycystic ovarian disease: US features in 104 patients. Radiology 1987; 163: 111-116.
59. Fox R, Corrigan E, Thomas PA, Hull MGR. The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests. Clin Endocrinol (Oxf) 1991; 34: 127-131.
60. Matsunaga I, Hata T, Kitao M. Ultrasonographic identification of polycystic ovary. Asia Oceania J Obstet Gynaecol 1985; 11: 227-232.
61. Ardaens Y, Robert Y, Lemaitre L, Fossati P, Dewailly D. Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis. Fertil Steril 1991; 55: 1062-1068.
62. Buckett WM, Bouzayen R, Watkin KL, Tulandi T, Tan SL. Ovarian stromal echogenicity in women with normal and polycystic ovaries. Hum Reprod 1999; 14: 618-621.
63. Robert Y, Dubrulle F, Gaillandre L, Ardaens Y, Thomas-Desrousseaux P, Lemaitre L, Dewailly D. Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification. Fertil Steril 1995; 64: 307-312.
64. Kyei-Mensah A, Maconochie N, Zaidi J, Pittrof R, Campbell S, Tan SL. Transvaginal three-dimensional ultrasound: reproducibility of ovarian and endometrial volume measurements. Fertil Steril 1998; 66: 718-722.
65. Nardo GL, Buckett WM, White D, Digesu A, Franks S, Khullar V. Three-dimensional assessment of ultrasound features in women with clomiphene citrate-resistant ovarian syndrome (PCOS): ovarian stromal volume does not correlate with biochemical indices. Hum Reprod 2002; 17: 1052-1055.
66. Fulghesu AM, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary sindrome: the ovarian stroma/total area ratio. Fertil Steril 2001; 76: 326-331.
67. Hann LE, Hall DA, McArdle CR, Seibel M. Polycystic ovarian disease: sonographic spectrum. Radiology 1984; 150: 531-534.
68. Nicolini U, Ferrazzi E, Bellotti M, Travaglino P, Elli R, Scaperrotta RC. The contribution of sonographic evaluation of ovarian size in patients with polycystic ovarian disease. J Ultrasound Med 1985; 4: 341-351.
69. Farber M, Madanes A, O'Briain DS, Millan VG, Nuran Turksoy R, Rule AH. Asymmetric hyperthecosis ovarii. Obstet Gynecol 1981; 57: 521-525.
70. Polson DW, Adams J, Steer PJ, Franks S. Unilateral polycystic ovary. Case report. Br J Obstet Gynaecol 1986; 93: 1100-1103.
71. Insler V, Lunenfeld B. Polycystic ovarian disease: a challenge and controversy. Gynecol Endocrinol 1990; 4: 51-69.
72. Battaglia C, Regnani G, Petraglia F, Primavera MR, Salvatori M, Volpe A. Polycystic ovary syndrome: it is always bilateral? Ultrasound Obstet Gynecol 1999; 14: 183-187.
73. Battaglia C, Regnani G, Artini PG, Giulini S, Genazzani AD, Genazzani AR, Volpe A. Polycystic ovary syndrome: a new ultrasonographic and color Doppler pattern. Gynecol Endocrinol 2000; 14: 417-424.
74. Amer SAKS, Li TC, Bygrave C, Sprigg A, Saravelos H, Cooke ID. An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries. Hum Reprod 2002; 17: 1616-1622.
75. Atiomo WU, Pearson S, Shaw S, Prentice A, Dubbins P. Ultrasound criteria in the diagnosis of polycystic ovary syndrome (PCOS). Ultrasound Med Biol 2000; 26: 977-980.
76. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 1992; 327: 157-162.
77. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated and biochemical features in young women. Clin Endocrinol (Oxf) 1999; 51: 779-786.
78. Carmina E, Wong L, Chang L, Paulson RJ, Sauer MV, Stanczyk FZ, Lobo RA. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound. Hum Reprod 1997; 12: 905-909.
79. Sagle M, Bishop K, Ridley N, Alexander FM, Michel M, Bonney RC, Beard RW, Franks S. Recurrent early miscarriage and polycystic ovaries. BMJ 1988; 297: 1027-1028.
80. Kousta E, White DM, Cela E, McCarthy MI, Franks S. The prevalence of polycystic ovaries with infertility. Hum Reprod 1999; 11: 2720-2723.
81. Eden JA, Place GD, Carter GD, Alaghband-Zadeh, Pawson M. Is the polycystic ovary a cause of infertility in the ovulatory woman. Clin Endocrinol (Oxf) 1989; 30: 77-82.
82. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinizing hormone concentrations on ovulation, conception and early pregnancy loss in the polycystic ovary syndrome. BMJ 1988; 297: 1024-1026.
83. Clarke AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, Norman RJ. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995; 10: 2705-2712.
84. Goswamy RK, Steptoe P. Doppler ultrasound studies of the uterine artery in spontaneous ovarian cycles. Hum Reprod 1988; 3: 721-726.
85. Collins W, Jurkovic D, Bourne T, Kurjak A, Campbell S. Ovarian morphology, endocrine function and intra-follicular blood flow during the periovulatory period. Hum Reprod 1991; 3: 319-324.
86. Bourne TH, Campbell S, Steer CV, Whitehead MI, Collins WP. Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer. BMJ 1989; 299: 1367-1370.
87. Kurjak A, Zalud I, Jurkovic D, Alfirevic Z, Miljan M. Transvaginal color flow Doppler for the assessment of pelvic circulation. Acta Obstet Gynecol 1989; 68: 131-135.
88. Kurjak K, Kupesic S. Uterine and ovarian perfusion changes from reproductive maturity to menopause. In Ultrasound and Infertility, Kupesic S, de Ziegler D (eds). Parthenon Publishing, London, 2000; 169-180.
89. Kurjak A, Kupesic-Urek S, Schulman H, Zalud I. Transvaginal color flow Doppler in the assessment of ovarian and uterine blood flow in infertile women. Fertil Steril 1991; 56: 870-873.
90. Kuriak A, Jurkovic D, Alfirevic Z, Zalud I. Transvaginal color Doppler imaging. J Clin Ultrasound 1990; 18: 227-234.
91. Kurjak A, Zalud I, Crvenkovic G. The assessment of pelvic circulation by transvaginal colour Doppler. Jpn J Med Ultrasound 1990; 17: 116-120.
92. Fleischer AC. Ultrasound imaging - 2000: assessment of utero-ovarian blood flow with transvaginal color Doppler sonography; potential clinical applications in infertility. Fertil Steril 1991; 55: 684-691.
93. Steer CV, Campbell S, Pampiglione J, Kingsland CR, Mason BA, Collins WP. Transvaginal color flow imaging of the uterine arteries during the ovarian and menstrual cycles. Hum Reprod 1990; 5: 391-395.
94. Battaglia C, Larocca E, Lanzani A, Valentini M, Genazzani AR. Doppler ultrasound studies of the uterine arteries in spontaneous and IVF stimulated ovarian cycles. Gynecol Endocrinol 1990; 4: 245-250.
95. Goswamy RK, Williams G, Steptoe PC. Decreased uterine perfusion - a cause of infertility. Hum Reprod 1988; 3: 955-959.
96. Mercè LT, Garcès D, Barco MJ, De La Fuente F. Intraovarian Doppler velocimetry in ovulatory, dysovulatory and anovulatory cycles. Ultrasound Obstet Gynecol 1992; 2: 197-202.
97. Sladkevicius P, Valentin L, Marsàl K. Blood flow velocity in the uterine and ovarian arteries during the normal menstrual cycle. Ultrasound Obstet Gynecol 1993; 3: 199-208.
98. Battaglia C, Artini PG, D'Ambrogio G, Genazzani AD, Genazzani AR. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol 1995; 172: 108-113.
99. Findlay JK. Angiogenesis in reproductive tissues. J Endocrinol 1986; 111: 357-366.
100. Kawakami M, Kubo K, Uemura T, Nagase M, Hayashi R. Involvement in ovarian innervation in steroid secretion. Endocrinology 1981; 109: 136-145.
101. Brannstrom M, Norman RJ. Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum Reprod 1993; 8: 1762-1775.
102. Horwitz KB, Horwitz LD. Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. J Clin Invest 1982; 69: 750-758.
103. Fisher GM, Swain ML. Effect of sex hormones on blood pressure and vascular connective tissue in castrated and non castrated rats. Am J Physiol 1977; 232: 617-621.
104. Ajossa S, Guerriero S, Paotetti AM, Orrù M, Melis GB. The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome. Fertil Steril 2002; 77: 1136-1140.
105. Zaidi J, Campbell S, Pittrof R, Kyei-Mensah A, Shaker A, Jacobs HS, Tan SL. Ovarian stromal blood flow in women with polycystic ovaries - a possible new marker for diagnosis? Hum Reprod 1995; 10: 1992-1995.
106. Aleem FA, Predanic M. Transvaginal color Doppler determination of the ovarian and uterine brood flow characteristics in polycystic ovary disease. Fertil Steril 1996; 65: 510-516.
107. Vrtacnik-Bokal E, Meden-Vrtovec H. Utero-ovarian arterial blood flow and hormonal profile in patients with polycystic ovary syndrome. Hum Reprod 1998; 13: 815-821.
108. Ajossa S, Guerriero S, Paoletti AM, Orrù M, Floris S, Mannias M, Melis GB. Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome. J Assist Reprod Genet 2001; 18: 436-440.
109. Dolz M, Osborne NG, Blanes J, Raga F, Abad-Velasco L, Villalobos A, Pellicer A, Bonilla-Musoles F. Polycystic ovarian syndrome: assessment with color Doppler angiography and three-dimensional ultrasonography. J Ultrasound Med 1999; 18: 303-313.
110. Pan HA, Wu MH, Cheng YC, Li CH, Chang FM. Quantification of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: a possible new marker for diagnosis. Hum Reprod 2002; 17: 201-206.
111. Battaglia C, Artini PG, Salvatori M, Giulini S, Petraglia F, Maxia N, Volpe A. Ultrasonographic patterns of polycystic ovaries: color Doppler and hormonal correlations. Ultrasound Obstet Gynecol 1998; 11: 332-336.
112. Avvad CK, Holeuwerger R, Silva VCG, Bordallo MAN, Breitenbach MMD. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence. Gynecol Endocrinol 2001; 15: 170-177.
113. Battaglia C, Artini PG, Genazzani AD, Florio P, Salvatori M, Sgherzi MR, Giulini S, Lombardo M, Volpe A. Color Doppler analysis in oligo- and amenorrheic women with polycystic ovary syndrome. Gynecol Endocrinol 1997; 11: 105-110.
114. Genazzani AD, Petraglia F, Battaglia C, Gamba O, Volpe A, Genazzani AR. A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulation function in patients with polycystic ovary syndrome. Fertil Steril 1997; 67: 463-468.
115. Battaglia C, Genazzani AD, Artini PG, Salvatori M, Giulini S, Volpe A. Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome. Ultrasound Obstet Gynecol 1998; 12: 180-187.
116. Battaglia C, Artini PG, Genazzani AD, Sgherzi MR, Salvatori M, Giulini S, Volpe A. Color Doppler analysis in lean and obese women with polycystic ovary syndrome. Ultrasound Obstet Gynecol 1996; 7: 342-346.
117. Wild RA, Van Nort JJ, Grubb B, Bachman W, Hartz A, Bartholomew M. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril 1990; 54: 255-259.